David Balderson, Vice President of Global Safety Operations

David Balderson, Global Vice President Safety Operations

Susan Najjar

Throughout his career, David has been a key driver of process improvement initiatives, from the development of processes to support the EU Clinical Trial Directive implementation (2004), through to the development of an electronic interface between the clinical trial and safety databases. Prior to joining Sciformix David he held senior leadership roles at Amgen US, first as Head of Global Safety Operations and then as Head of Global Regulatory Operations. David spent 7 years in Pharmacovigilance at GSK in the UK. David holds a BSc in Physiology and Pharmacology and PhD in Neuroscience, both from the University of Manchester, UK.